Conditions: Diabetic Neuropathy, Painful
Keywords: Diabetic peripheral neuropathy Lyrica pregabalin pain
Allocation: RANDOMIZED | Intervention model: 
Enrollment: 633
Healthy volunteers: no

Brief summary:
Patients will be switched from their current medication for painful diabetic peripheral neuropathy to evaluate the safety and efficacy of pregabalin as compared to placebo. All patients will receive pregabalin, and half of patients will receive placebo at some point during the study.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: pregabalin (Lyrica) intervention 2: Placebo
Intervention descriptions: intervention 1: Lyrica 150-300 mg/day. Medication is supplied as capsules and given 3 times daily. intervention 2: Placebo is supplied as capsules and given 3 times daily.

Protocol document: